AiViva
Early Stage
Developing treatments that change lives
Analytics
Raised: $159,973
Aggregate Commitments $
Platform
StartEngine
Start Date
06/17/2022
Close Date
08/30/2022
Min. Goal
$10,000
Max. Goal
$5,000,000
Min. Investment
$400
Security Type
Equity - Common
Funding Type
RegCF
Series
Seed
Price Per Share
$2.00
Pre-Money Valuation
$48,772,314
Rolling Commitments $
Status
Active
Reporting Date
06/25/2022
Days Remaining
66
% of Min. Goal
1,600%
% of Max. Goal
3%
Likelihood of Max
Avg. Daily Raise
$19,997
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Location
Newport Beach, California
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
AiViva, with a valuation of $48.8 million, is raising funds on StartEngine. It is a biotechnology company that has created proprietary technology and new treatments in the fields of urology, oncology, dermatology, and ophthalmology. The JEL technology of AiViva enhances the benefits of drugs and prolongs their therapeutic effects, thus reducing the treatment frequency and improving outcomes. AiViva is conducting four clinical trials focused on wet AMD, non-melanoma skin cancer, and prostate disorders. Diane Tang-Liu founded AiViva in February 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5,000,000. The campaign proceeds will be used for research and development and the advancement of novel treatment paradigms.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$17,000 |
$153,000 |
|
COGS |
$0 |
$0 |
|
Tax |
$4,070 |
$800 |
| ||
| ||
|
Net Income |
$-3,960,872 |
$-4,542,477 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$3,601,734 |
$5,419,620 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$4,583,591 |
$8,589,570 |
|
Short-Term Debt |
$437,051 |
$597,651 |
|
Long-Term Debt |
$23,892 |
$0 |
|
Total Liabilities |
$460,943 |
$597,651 |
Financials as of: 06/17/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Analyst Report 
Pending Review